Pharmaceutical Contract Sales Outsourcing (CSO) Market: Introduction
According to the report, the global pharmaceutical contract sales outsourcing (CSO) market was valued at US$ 7 Bn in 2020 and is projected to expand at a CAGR of ~7% from 2021 to 2031. Increase in R&D and other operating costs in pharmaceutical industries induces medium and large pharmaceutical companies to outsource their sales operations, as it offers cost controls, better results, and flexibility in terms of operations is anticipated to drive the global pharmaceutical contract sales outsourcing (CSO) market from 2021 to 2031.
North America is expected to account for a significant share of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period. Well-established healthcare, early adoption of technologically advanced services, and increase in acceptance & demand for pharmaceutical contract sales outsourcing services are the major factors likely to drive the market in the region during the forecast period. The market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2031.
Digitalization of Services Provided by CSOs to Propel Market
Improved and advanced services provided by CSOs such as in the field of non-personal promotions are anticipated to drive the global market during the forecast period. Large as well as small pharmaceutical companies are looking for drugs to cost effectively and quickly enter their pipelines and CSOs play an important role in this endeavor.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28562
The rise in virtual detailing in outsourcing services is increasing dependence on CSO services. The surge in the usage of teledetailng propels the non-personal promotion of outsourcing. These advanced functions, including sales force and customer support are well-established in a CSO, and hence, can help the brand to get market recognition faster.
Personal Promotion to Dominate Global Market
In terms of service, the global pharmaceutical contract sales outsourcing (CSO) market has been classified into personal promotion, non-personal promotion, and others. The personal promotion segment has been split into promotional sales team, key account management, and vacancy management. The non-personal promotion segment has been segregated into tele-detailing, interactive e-detailing, customer service, medical science liaisons, patient engagement services, and others.
Request for Analysis of COVID-19 Impact on Pharmaceutical Contract Sales Outsourcing (CSO) Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=28562
The personal promotion segment is expected to dominate the global pharmaceutical contract sales outsourcing (CSO) market from 2021 to 2031. Significant increase in research & development costs, technological advancements, and product innovations have induced several pharmaceutical companies to outsource sales services to CSOs. This drives the personal promotion services segment.
Oncology to Grow at Faster Rate
Based on therapeutic area, the global pharmaceutical contract sales outsourcing (CSO) market has been categorized into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment is likely to expand at a higher CAGR during the forecast period.
Pre Book Pharmaceutical Contract Sales Outsourcing (CSO) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=28562<ype=S
The report provides profiles of leading players operating in the global pharmaceutical contract sales outsourcing (CSO) market. These include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA, MaBiCo, QFR Solutions, Pharmaforce Ireland Ltd., Sales Focus, Inc., Amplity Health, and PharmaLex GmbH.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Mr. Rohit Bhisey
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Follow Us: Twitter | LinkedIn
Why pay for news and opinions when you can get them for free?
Subscribe for free now!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
FINANCE4 days ago
Backpack Raises $17 Million Strategic Series A Round Led by Placeholder VC
NEWS4 days ago
Record year for wind farms raises hope for EU green energy goals
NEWS1 day ago
M&A may breathe new life into Europe’s neglected telecoms
NEWS4 days ago
Russia diamond producer Alrosa’s annual net profit drops 15.2%